arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 1903.07308q-bio.BM
收藏

纳米抗体相互作用揭示了芬兰型淀粉样凝溶胶蛋白变体的结构,动力学和蛋白毒性

Nanobody interaction unveils structure, dynamics and proteotoxicity of the Finnish-type amyloidogenic gelsolin variant

Toni Giorgino, Davide Mattioni, Amal Hassan, Mario Milani, Eloise Mastrangelo, Alberto Barbiroli, Adriaan Verhelle, Jan Gettemans, Maria Monica Barzago, Luisa D… 展开作者

Toni Giorgino, Davide Mattioni, Amal Hassan, Mario Milani, Eloise Mastrangelo, Alberto Barbiroli, Adriaan Verhelle, Jan Gettemans, Maria Monica Barzago, Luisa Diomede, Matteo de Rosa

摘要:

AGel淀粉样变性,以前称为芬兰型家族性淀粉样变性,是由血浆凝溶胶蛋白的蛋白水解片段的病理性聚集引起的。到目前为止,凝溶胶蛋白基因中的四个突变已被报道为该疾病的原因。虽然D187 N是第一个被鉴定的变异体,也是最好的变异体,但它的结构迄今为止一直是难以捉摸的。利用最近开发的靶向凝溶胶蛋白的纳米抗体,我们能够稳定D187 N蛋白的G2结构域,并首次获得其高分辨率晶体结构。在纳米抗体稳定的构象中,D187 N取代的主要作用是损害钙结合能力,导致G2的C末端尾部不稳定。然而,分子动力学模拟显示,在不存在纳米抗体的情况下,D187 N突变的G2进一步错误折叠,最终暴露其疏水核心和弗林蛋白酶切割位点。纳米抗体的保护作用是基于不同G2突变体(D187 N、G167 R和N184 K)的热力学稳定性的增强。特别地,纳米抗体降低了动态拉伸的灵活性,并且最显著地降低了C-末端尾部的构象熵,否则通过Ca 2+离子的存在而稳定。还应用基于秀丽隐杆线虫的测定来定量突变体的蛋白毒性潜力,并确定纳米抗体稳定化是否转化为生物学相关效应。在体内成功地保护G2毒性表明使用C。elegans作为研究AGel淀粉样变性的机制和快速筛选新疗法的工具。

英文摘要:

AGel amyloidosis, formerly known as familial amyloidosis of the Finnish-type, is caused by pathological aggregation of proteolytic fragments of plasma gelsolin. So far, four mutations in the gelsolin gene have been reported as responsible for the disease. Although D187N is the first identified variant and the best characterized, its structure has been hitherto elusive. Exploiting a recently-developed nanobody targeting gelsolin, we were able to stabilize the G2 domain of the D187N protein and obtained, for the first time, its high-resolution crystal structure. In the nanobody-stabilized conformation, the main effect of the D187N substitution is the impairment of the calcium binding capability, leading to a destabilization of the C-terminal tail of G2. However, molecular dynamics simulations show that in the absence of the nanobody, D187N-mutated G2 further misfolds, ultimately exposing its hydrophobic core and the furin cleavage site. The nanobody's protective effect is based on the enhancement of the thermodynamic stability of different G2 mutants (D187N, G167R and N184K). In particular, the nanobody reduces the flexibility of dynamic stretches, and most notably decreases the conformational entropy of the C-terminal tail, otherwise stabilized by the presence of the Ca2+ ion. A Caenorhabditis elegans-based assay was also applied to quantify the proteotoxic potential of the mutants and determine whether nanobody stabilization translates into a biologically relevant effect. Successful protection from G2 toxicity in vivo points to the use of C. elegans as a tool for investigating the mechanisms underlying AGel amyloidosis and rapidly screen new therapeutics.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑